Solid Biosciences
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
500 Rutherford Ave Fl 3, Charlestown, Ma...Phone Number
(617) 337-4680Website
www.solidbio.comRevenue
$21.1 MillionStock Symbol
SLDBIndustry
About Solid Biosciences
Solid Biosciences is a life sciences company focused on advancing a portfolio of gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy (Duchenne), SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia (CPVT), AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy, and additional assets for the treatment of fatal cardiac diseases. Solid is advancing its diverse pipeline across rare neuromuscular and cardiac diseases, bringing together experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted, Solids mandate is to improve the daily lives of patients living with these devastating diseases.Explore more
Solid Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Solid Biosciences
Compare insights from companies similar to Solid Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Solid Biosciences Tech Stack
A closer look at the technologies used by Solid Biosciences
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Solid Biosciences
Sign Up For FreeTo access detailed company insights
Solid Biosciences is a life sciences company focused on advancing a portfolio of gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy (Duchenne), SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia (CPVT), AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy, and add... Read More
